je.st
news
Tag: announces development
QuantumSphere Announces Joint Development Agreement With Casale, S.A.
2015-06-01 04:14:39| chemicalonline News Articles
QuantumSphere, Inc. (QSI), a leader in nanoscale catalyst technologies providing production efficiencies to multi-billion dollar industrial chemical processes, today announced that it has entered into a multi-year Joint Development Agreement with Swiss-based Casale, S.A. (Casale)
Tags: development
agreement
joint
announces
SABIC Announces Global Application Development Focus to Advance Additive Manufacturing Technology
2015-03-26 11:31:14| Industrial Newsroom - All News for Today
Orlando, Florida Leveraging its global technology centers in the Americas, Europe, Asia and Saudi Arabia, SABIC announced that it is expanding the company's application development focus in additive manufacturing technology. The move further underscores SABIC's commitment to this evolving technology that is...
Tags: technology
development
application
global
Software Company Anahata Announces Perth's Street Development Industry
2015-03-11 06:35:46| publicworks Home Page
Anahata provides expertise and software design services to business organizations including the public sector and learning institutions
Tags: software
company
development
street
Park Systems Announces Joint Development Partnership with imec to Develop Nanoscale AFM Metrology Solutions for Semiconductor Manufacturing
2015-03-09 11:31:11| Industrial Newsroom - All News for Today
SUWON, Korea Park Systems, world-leader in Atomic Force Microscopes (AFM) announced today they have signed a Joint Development Project (JDP) with nanoelectronics research center imec, to develop in-line AFM metrology solutions of future technology nodes including but not limited to surface roughness, thickness...
Tags: development
systems
park
solutions
Momenta Pharmaceuticals Announces Publication Revealing Development Of A Novel Process To Generate High-Quality Hyper-Sialylated IVIg Drug Candidate In PNAS
2015-03-04 05:59:44| drugdiscoveryonline Home Page
Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that results from preclinical studies on its hyper-sialylated IVIg (hsIVIg) program were published in this week's Early Edition of Proceedings of the National Academy of Sciences (PNAS)
Tags: development
process
publication
drug
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] next »